U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776509) titled 'A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus' on Aug. 10.
Brief Summary: The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment.
Study Start Date: Aug. 21
Study Type: INTERVENTIONAL
Condition:
Obesity or Overweight
Weight-Related Comorbidity
With/Without Diabetes Mellitus, Type 2
Intervention:
DRUG: AZD6234...